Document is current
Any future updates will be listed below
-
Authors
Liu, Honghong
Guo, Rui
Zhang, Xiaojun
Ji, Huijuan
Sun, Shuwei
Sun, Shasha
Liu, Jiayong
Yang, Zhi
Wang, Ruimin https://orcid.org/0000-0001-9948-2633
- License Information
-
More Information
Article History
Received: 29 June 2025
Accepted: 29 September 2025
First Online: 15 October 2025
Declarations
:
: The ethical approval was obtained from local institutional review board. The informed consent was obtained from individual participant included in the study.
: All of the authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Sinotau Pharmaceutical Group provided 177 Lu-FAPI-XT (including precursors and radionuclides) for the study but had no role in study design, data collection, analysis, interpretation, or manuscript preparation, and did not provide any financial or other research support.
